Literature DB >> 26334756

Understanding PK/PD.

Jason A Roberts1,2,3, Fabio Silvio Taccone4, Jeffrey Lipman5,6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26334756     DOI： 10.1007/s00134-015-4032-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  15 in total

1.  Pharmacodynamics of cefepime in patients with Gram-negative infections.

Authors:  Vincent H Tam; Peggy S McKinnon; Ronda L Akins; Michael J Rybak; George L Drusano
Journal:  J Antimicrob Chemother       Date:  2002-09       Impact factor: 5.790

2.  Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI Study.

Authors:  J A Roberts; V Stove; J J De Waele; B Sipinkoski; B McWhinney; J P J Ungerer; M Akova; M Bassetti; G Dimopoulos; K-M Kaukonen; D Koulenti; C Martin; P Montravers; J Rello; A Rhodes; T Starr; S C Wallis; J Lipman
Journal:  Int J Antimicrob Agents       Date:  2014-02-22       Impact factor: 5.283

3.  The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?

Authors:  Stijn Blot; Jeffrey Lipman; Darren M Roberts; Jason A Roberts
Journal:  Diagn Microbiol Infect Dis       Date:  2014-01-24       Impact factor: 2.803

Review 4.  Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation.

Authors:  Janattul-Ain Jamal; Caleb J P Economou; Jeffrey Lipman; Jason A Roberts
Journal:  Curr Opin Crit Care       Date:  2012-10       Impact factor: 3.687

5.  Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations.

Authors:  Andrew A Udy; Julie M Varghese; Mahdi Altukroni; Scott Briscoe; Brett C McWhinney; Jacobus P Ungerer; Jeffrey Lipman; Jason A Roberts
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

6.  Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.

Authors:  Giuseppe Valenza; Harald Seifert; Sabine Decker-Burgard; Joerg Laeuffer; Ian Morrissey; Reinier Mutters
Journal:  Int J Antimicrob Agents       Date:  2012-01-09       Impact factor: 5.283

7.  Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections.

Authors:  Chonghua Li; Xiaoli Du; Joseph L Kuti; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2007-02-16       Impact factor: 5.191

8.  Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens.

Authors:  Jason A Roberts; Fabio Silvio Taccone; Andrew A Udy; Jean-Louis Vincent; Frédérique Jacobs; Jeffrey Lipman
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

9.  Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.

Authors:  A Forrest; D E Nix; C H Ballow; T F Goss; M C Birmingham; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

10.  DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?

Authors:  Jason A Roberts; Sanjoy K Paul; Murat Akova; Matteo Bassetti; Jan J De Waele; George Dimopoulos; Kirsi-Maija Kaukonen; Despoina Koulenti; Claude Martin; Philippe Montravers; Jordi Rello; Andrew Rhodes; Therese Starr; Steven C Wallis; Jeffrey Lipman
Journal:  Clin Infect Dis       Date:  2014-01-14       Impact factor: 9.079
View more
  17 in total

Review 1.  Challenges in the management of septic shock: a narrative review.

Authors:  Daniel De Backer; Maurizio Cecconi; Jeffrey Lipman; Flavia Machado; Sheila Nainan Myatra; Marlies Ostermann; Anders Perner; Jean-Louis Teboul; Jean-Louis Vincent; Keith R Walley
Journal:  Intensive Care Med       Date:  2019-02-11       Impact factor: 17.440

Review 2.  Focus on severe infections.

Authors:  Kevin B Laupland; Jose-Artur Paiva; Jean-Francois Timsit
Journal:  Intensive Care Med       Date:  2017-05-13       Impact factor: 17.440

Review 3.  The intensive care medicine research agenda on septic shock.

Authors:  Anders Perner; Anthony C Gordon; Derek C Angus; Francois Lamontagne; Flavia Machado; James A Russell; Jean-Francois Timsit; John C Marshall; John Myburgh; Manu Shankar-Hari; Mervyn Singer
Journal:  Intensive Care Med       Date:  2017-05-12       Impact factor: 17.440

Review 4.  Rationalizing antimicrobial therapy in the ICU: a narrative review.

Authors:  Jean-François Timsit; Matteo Bassetti; Olaf Cremer; George Daikos; Jan de Waele; Andre Kallil; Eric Kipnis; Marin Kollef; Kevin Laupland; Jose-Artur Paiva; Jesús Rodríguez-Baño; Étienne Ruppé; Jorge Salluh; Fabio Silvio Taccone; Emmanuel Weiss; François Barbier
Journal:  Intensive Care Med       Date:  2019-01-18       Impact factor: 17.440

Review 5.  The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship.

Authors:  Marin H Kollef; Matteo Bassetti; Bruno Francois; Jason Burnham; George Dimopoulos; Jose Garnacho-Montero; Jeffrey Lipman; Charles-Edouard Luyt; David P Nicolau; Maarten J Postma; Antonio Torres; Tobias Welte; Richard G Wunderink
Journal:  Intensive Care Med       Date:  2017-02-04       Impact factor: 17.440

Review 6.  Current research priorities in perioperative intensive care medicine.

Authors:  Michael A Gillies; Michael Sander; Andrew Shaw; Duminda N Wijeysundera; John Myburgh; Cesar Aldecoa; Ib Jammer; Suzana M Lobo; Naomi Pritchard; Michael P W Grocott; Marcus J Schultz; Rupert M Pearse
Journal:  Intensive Care Med       Date:  2017-06-08       Impact factor: 17.440

Review 7.  Update on ventilator-associated pneumonia.

Authors:  Jean-Francois Timsit; Wafa Esaied; Mathilde Neuville; Lila Bouadma; Bruno Mourvllier
Journal:  F1000Res       Date:  2017-11-29

8.  Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis.

Authors:  K E Stott; H Pertinez; M G G Sturkenboom; M J Boeree; R Aarnoutse; G Ramachandran; A Requena-Méndez; C Peloquin; C F N Koegelenberg; J W C Alffenaar; R Ruslami; A Tostmann; S Swaminathan; H McIlleron; G Davies
Journal:  J Antimicrob Chemother       Date:  2018-09-01       Impact factor: 5.790

Review 9.  The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development.

Authors:  Zhengying Zhou; Jinwei Zhu; Muhan Jiang; Lan Sang; Kun Hao; Hua He
Journal:  Pharmaceutics       Date:  2021-05-12       Impact factor: 6.321

10.  Bloodstream infections in critically ill patients: an expert statement.

Authors:  Jean-François Timsit; Etienne Ruppé; François Barbier; Alexis Tabah; Matteo Bassetti
Journal:  Intensive Care Med       Date:  2020-02-11       Impact factor: 17.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.